DGX Quest Diagnostics PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: DGX
- PE Ratio
As of Nov 5, 2025, the DGX stock has a PE ratio of 20.63. The calculation is based on the latest EPS of $8.64 and the stock price of $178.26 per share. The PE ratio currently is comparable to its last 4-quarter average.
DGX PE ratio history
The mean historical PE ratio of Quest Diagnostics over the last ten years is 16.57. The current 20.63 P/E ratio is 25% higher than the historical average. Looking back at the last ten years, DGX's PE ratio peaked in the Sep 2025 quarter at 22.06, with a price of $190.58 and an EPS of $8.64. The Jun 2021 quarter marked the lowest point at 7.74, with a price of $131.97 and an EPS of $17.06.
Quest Diagnostics PE ratio by year
Maximum annual increase: 82.59% in 2014
Maximum annual decrease: -42.57% in 2013
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 19.39 | 6.71% | $150.86 | $7.78 |
| 2023 | 18.17 | -5.9% | $137.88 | $7.59 |
| 2022 | 19.31 | 76.83% | $156.44 | $8.1 |
| 2021 | 10.92 | -2.67% | $173.01 | $15.85 |
| 2020 | 11.22 | -33.17% | $119.17 | $10.62 |
| 2019 | 16.79 | 8.67% | $106.79 | $6.36 |
| 2018 | 15.45 | -11.66% | $83.27 | $5.39 |
| 2017 | 17.49 | -12.86% | $98.49 | $5.63 |
| 2016 | 20.07 | 38.8% | $91.9 | $4.58 |
| 2015 | 14.46 | -17.42% | $71.14 | $4.92 |
| 2014 | 17.51 | 82.59% | $67.06 | $3.83 |
| 2013 | 9.59 | -42.57% | $53.54 | $5.58 |
| 2012 | 16.7 | -15.14% | $58.27 | $3.49 |
| 2011 | 19.68 | 48.75% | $58.06 | $2.95 |
| 2010 | 13.23 | -14.31% | $53.97 | $4.08 |
Quest Diagnostics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 22.06 | 4.01% | $190.58 | $8.64 |
| Jun 2025 | 21.21 | 0.43% | $179.63 | $8.47 |
| Mar 2025 | 21.12 | 8.92% | $169.2 | $8.01 |
| Dec 2024 | 19.39 | -6.06% | $150.86 | $7.78 |
| Sep 2024 | 20.64 | 13.1% | $155.25 | $7.52 |
| Jun 2024 | 18.25 | 3.22% | $136.88 | $7.5 |
| Mar 2024 | 17.68 | -2.7% | $133.11 | $7.53 |
| Dec 2023 | 18.17 | 1.4% | $137.88 | $7.59 |
| Sep 2023 | 17.92 | -10.62% | $121.86 | $6.8 |
| Jun 2023 | 20.05 | -1.81% | $140.56 | $7.01 |
| Mar 2023 | 20.42 | 5.75% | $141.48 | $6.93 |
| Dec 2022 | 19.31 | 63.51% | $156.44 | $8.1 |
| Sep 2022 | 11.81 | 9.25% | $122.69 | $10.39 |
| Jun 2022 | 10.81 | 21.19% | $132.98 | $12.3 |
| Mar 2022 | 8.92 | -18.32% | $136.86 | $15.35 |
DGX Price vs fair value
DGX average PE ratio chart
DGX's current PE ratio is higher than the 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 20.63, DGX ranks lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 25.01, Quest Diagnostics's price to earnings (P/E) is 18% lower.
DGX PE vs peers
DGX's PE ratio stands lower than its peer stocks LH and QGEN.
| Stock name | PE ratio | Market cap |
|---|---|---|
| DGX Quest Diagnostics Inc | 20.46 | $19.67B |
| LH Laboratory Corp Of America Holdings | 24.16 | $20.53B |
| QGEN Qiagen NV | 25.43 | $9.41B |
| NEO Neogenomics Inc | N/A | $1.34B |
Frequently asked questions
What is Quest Diagnostics's PE ratio?
DGX's price to earnings ratio is 20.63 as of Nov 5, 2025.
What is the 3-year average PE ratio for Quest Diagnostics (DGX)?
Over the last 3 years, the average price to earnings ratio for DGX stock is 19.69.
What is the 5-year average PE ratio for Quest Diagnostics (DGX)?
Over the last 5 years, the average price to earnings ratio for DGX stock is 15.79.
What is the highest PE ratio for DGX?
Over the last ten years, the Sep 2025 quarter recorded the highest quarterly PE ratio at 22.06.
How does the current PE ratio for DGX compare to its historical average?
DGX's current price to earnings ratio is 25% above its 10-year historical average.
How is DGX's PE ratio calculated (Quest Diagnostics PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 5, 2025), Quest Diagnostics's share price is $178.26. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $8.64. Therefore, Quest Diagnostics's PE ratio for today is 20.63. PE RATIO(20.63) = STOCK PRICE($178.26) / TTM EPS($8.64)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.